Mega Webinar on Jan 29th: Will 2021 be a boom or bust?
Here is the latest financial fact sheet of Piramal Enterprises. For more details, see the Piramal Enterprises quarterly results and Piramal Enterprises share price and chart. For a sector overview, read our pharmaceuticals sector report.
% ch | % | -4.9 |
No. of shares | m | 225.54 |
% ch week | % | -6.9 |
% ch 1-mth | % | 10.3 |
% ch 12-mth | % | -7.7 |
52 week H/L | Rs | 1,727.6/608.0 |
No. of Mths Year Ending |
12 Mar-15* |
12 Mar-16* |
12 Mar-17* |
12 Mar-18* |
12 Mar-19* |
5-Yr Chart Click to enlarge
|
---|
PIRAMAL ENTERPRISES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 949 | 1,065 | 2,095 | 3,083 | 3,303 | |
Low | Rs | 522 | 805 | 1,025 | 1,902 | 1,797 | |
Sales per share (Unadj.) | Rs | 296.9 | 367.5 | 492.8 | 589.7 | 716.5 | |
Earnings per share (Unadj.) | Rs | 165.2 | 52.4 | 72.6 | 284.0 | 79.7 | |
Diluted earnings per share | Rs | 126.4 | 40.1 | 55.5 | 227.0 | 65.2 | |
Cash flow per share (Unadj.) | Rs | 182.0 | 67.2 | 94.7 | 310.5 | 107.9 | |
Dividends per share (Unadj.) | Rs | 20.00 | 17.50 | 21.00 | 25.00 | 28.00 | |
Adj. dividends per share | Rs | 15.30 | 13.39 | 16.07 | 19.98 | 22.90 | |
Dividend yield (eoy) | % | 2.7 | 1.9 | 1.3 | 1.0 | 1.1 | |
Book value per share (Unadj.) | Rs | 778.0 | 750.4 | 862.5 | 1,473.5 | 1,477.5 | |
Adj. book value per share | Rs | 595.3 | 574.1 | 659.9 | 1,177.7 | 1,208.4 | |
Shares outstanding (eoy) | m | 172.56 | 172.56 | 172.56 | 180.27 | 184.45 | |
Bonus/Rights/Conversions | - | - | - | IS | IS | ||
Price / Sales ratio | x | 2.5 | 2.5 | 3.2 | 4.2 | 3.6 | |
Avg P/E ratio | x | 4.5 | 17.8 | 21.5 | 8.8 | 32.0 | |
P/CF ratio (eoy) | x | 4.0 | 13.9 | 16.5 | 8.0 | 23.6 | |
Price / Book Value ratio | x | 0.9 | 1.2 | 1.8 | 1.7 | 1.7 | |
Dividend payout | % | 12.1 | 33.4 | 28.9 | 8.8 | 35.1 | |
Avg Mkt Cap | Rs m | 126,901 | 161,344 | 269,194 | 449,332 | 470,292 | |
No. of employees | `000 | 2.4 | 3.8 | 4.0 | 6.8 | 7.8 | |
Total wages/salary | Rs m | 12,948 | 16,831 | 17,939 | 19,881 | 22,504 | |
Avg. sales/employee | Rs Th | 21,167.8 | 16,763.2 | 21,190.3 | 15,535.6 | 16,899.4 | |
Avg. wages/employee | Rs Th | 5,350.2 | 4,449.0 | 4,470.1 | 2,905.4 | 2,877.7 | |
Avg. net profit/employee | Rs Th | 11,776.7 | 2,391.6 | 3,120.0 | 7,482.5 | 1,879.9 |
PIRAMAL ENTERPRISES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 51,226 | 63,415 | 85,037 | 106,310 | 132,153 | |
Other income | Rs m | 2,542 | 2,517 | 2,338 | 2,595 | 3,128 | |
Total revenues | Rs m | 53,768 | 65,932 | 87,374 | 108,906 | 135,281 | |
Gross profit | Rs m | 8,855 | 16,772 | 34,991 | 51,599 | 66,290 | |
Depreciation | Rs m | 2,899 | 2,555 | 3,817 | 4,773 | 5,202 | |
Interest | Rs m | 5,106 | 9,591 | 20,310 | 29,783 | 44,097 | |
Profit before tax | Rs m | 3,392 | 7,144 | 13,202 | 19,638 | 20,119 | |
Minority Interest | Rs m | 3 | 1,942 | 1,699 | 2,801 | 3,194 | |
Prior Period Items | Rs m | 1,593 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 26,962 | 457 | -100 | 0 | 0 | |
Tax | Rs m | 3,450 | 495 | 2,281 | -28,764 | 8,611 | |
Profit after tax | Rs m | 28,500 | 9,047 | 12,520 | 51,203 | 14,701 | |
Gross profit margin | % | 17.3 | 26.4 | 41.1 | 48.5 | 50.2 | |
Effective tax rate | % | 101.7 | 6.9 | 17.3 | -146.5 | 42.8 | |
Net profit margin | % | 55.6 | 14.3 | 14.7 | 48.2 | 11.1 |
PIRAMAL ENTERPRISES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 47,701 | 44,928 | 87,590 | 118,154 | 122,742 | |
Current liabilities | Rs m | 47,999 | 103,802 | 333,436 | 217,285 | 310,810 | |
Net working cap to sales | % | -0.6 | -92.8 | -289.1 | -93.2 | -142.3 | |
Current ratio | x | 1.0 | 0.4 | 0.3 | 0.5 | 0.4 | |
Inventory Days | Days | 47 | 42 | 31 | 27 | 23 | |
Debtors Days | Days | 58 | 56 | 48 | 47 | 39 | |
Net fixed assets | Rs m | 67,735 | 78,803 | 108,523 | 113,727 | 116,904 | |
Share capital | Rs m | 345 | 345 | 345 | 361 | 369 | |
"Free" reserves | Rs m | 133,910 | 129,138 | 148,481 | 265,263 | 272,161 | |
Net worth | Rs m | 134,255 | 129,484 | 148,826 | 265,624 | 272,530 | |
Long term debt | Rs m | 36,873 | 74,740 | 144,957 | 242,206 | 270,196 | |
Total assets | Rs m | 220,026 | 309,797 | 482,394 | 728,004 | 856,261 | |
Interest coverage | x | 1.7 | 1.7 | 1.7 | 1.7 | 1.5 | |
Debt to equity ratio | x | 0.3 | 0.6 | 1.0 | 0.9 | 1.0 | |
Sales to assets ratio | x | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | |
Return on assets | % | 15.3 | 6.0 | 6.8 | 11.1 | 6.9 | |
Return on equity | % | 21.2 | 7.0 | 8.4 | 19.3 | 5.4 | |
Return on capital | % | 21.7 | 9.4 | 12.0 | 10.3 | 12.4 | |
Exports to sales | % | 19.5 | 17.9 | 0 | 0 | 0 | |
Imports to sales | % | 8.5 | 6.9 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 10,009 | 11,362 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 4,374 | 4,364 | 0 | 0 | 0 | |
Fx inflow | Rs m | 12,010 | 14,435 | 15,001 | 15,110 | 15,200 | |
Fx outflow | Rs m | 5,740 | 5,183 | 5,150 | 4,298 | 4,889 | |
Net fx | Rs m | 6,270 | 9,253 | 9,851 | 10,813 | 10,312 |
PIRAMAL ENTERPRISES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -22,069 | -69,562 | -100,567 | -159,666 | -115,975 | |
From Investments | Rs m | 61,771 | -6,040 | -24,028 | -17,677 | -8,265 | |
From Financial Activity | Rs m | -38,646 | 75,439 | 135,705 | 186,503 | 107,525 | |
Net Cashflow | Rs m | 1,056 | -163 | 11,376 | 9,364 | -16,650 |
Share Holding
|
Company Information
|
CHM: Ajay G. Piramal | COMP SEC: Leonard D' Souza | YEAR OF INC: 1947 | BSE CODE: 500302 | FV (Rs): 2 | DIV YIELD (%): 1.5 |
Read: PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: IPCA LABS GLENMARK PHARMA CADILA HEALTHCARE NOVARTIS FULFORD INDIA
Compare PIRAMAL ENTERPRISES With: IPCA LABS GLENMARK PHARMA CADILA HEALTHCARE NOVARTIS FULFORD INDIA
Compare PIRAMAL ENTERPRISES With: ACTAVIS (US) MYLAN (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
The market scaled new life-time highs this week but it was the bears who took control. The benchmark indices, Sensex and Nifty ended mostly flat for the week but the momentum was in favour of the bears.
For the quarter ended June 2020, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 22.1% YoY). Sales on the other hand came in at Rs 29 bn (down 16.2% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.
For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.
Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.
More Views on NewsWere you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
Our ace stock picker is ready to capitalise on a big growth opportunity.
The pandemic failed to thwart Richa's investing success formula for 2020.
More